Detail Information of Transcriptional Regulations
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0544 Transporter Info | ||||
| Gene Name | KCNA5 | ||||
| Transporter Name | Voltage-gated potassium channel subunit Kv1.5 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Transcriptional Regulation of This DT (TSR) | ||||||
|---|---|---|---|---|---|---|
|
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
HIF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Repression of KCNA5 gene in pulmonary arterial hypertension condition | [1] | ||||
|
TF Protein Name |
Hypoxia-inducible factor 1-alpha | Transcription Factor Info | ||||
|
Studied Phenotype |
Pulmonary arterial hypertension [ICD11: BB01.0] | |||||
|
Tissue |
Lung | |||||
|
Related DT Changes |
Down regulating | |||||
|
Experimental Material |
Sprague-Dawley rats | |||||
|
Detailed Description |
Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to repress the transcription of KCNA5 gene in pulmonary arterial hypertension condition, which leads to a decreased expression of the drug transporter Voltage-gated potassium channel subunit Kv1.5. | |||||
|
Class 3.4: Heat shock factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
HSF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Activation of KCNA5 gene in cervical cancer condition | [2] | ||||
|
TF Protein Name |
Heat shock factor protein 1 | Transcription Factor Info | ||||
|
Studied Phenotype |
Cervical cancer [ICD11: 2C77] | |||||
|
Tissue |
Cervix | |||||
|
Related DT Changes |
Up regulating | |||||
|
Experimental Material |
Human human papillomavirus-related endocervical adenocarcinoma cells (HeLa) | |||||
|
Detailed Description |
Heat shock factor protein 1 (HSF1) has been reported to activate the transcription of KCNA5 gene in cervical cancer condition, which leads to an increased expression of the drug transporter Voltage-gated potassium channel subunit Kv1.5. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.